Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|August 9, 2014
Pegylated-IFNα2a for HIV/hepatitis C virus coinfected patients: out with the old, in with the newKian Bichoupan, Douglas T Dieterich
Drugs|May 29, 2014
Hepatitis C in HIV-infected patients: impact of direct-acting antiviralsKian Bichoupan, Douglas T Dieterich
Expert Opinion on Drug Metabolism & Toxicology|October 2, 2013
The pharmacokinetic evaluation of boceprevir for treatment of hepatitis C virusHari Shankar, Kian Bichoupan, Douglas T Dieterich
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 31, 2013
Interferon-free regimens for hepatitis C: combine and conquerValérie Martel-Laferrière, Kian Bichoupan, Douglas T Dieterich
Journal of Clinical Gastroenterology|November 1, 2013
Hepatitis C direct-acting antiviral agents: changing the paradigm of hepatitis C treatment in HIV-infected patientsValérie Martel-Laferrière, Kian Bichoupan, Douglas T Dieterich
Current HIV/AIDS Reports|July 6, 2014
HIV-hepatitis C virus co-infection in the era of direct-acting antiviralsKian Bichoupan, Douglas T Dieterich, Valérie Martel-Laferrière
BMC Gastroenterology|October 19, 2014
MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathyValérie Martel-Laferrière, Caitlin Homberger, Kian Bichoupan, et al.
World Journal of Gastroenterology|November 26, 2015
Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugsJoshua Hartman, Kian Bichoupan, Neal Patel, et al.
Journal of Addiction Medicine|August 21, 2015
Primary Care-Based Hepatitis C Treatment Outcomes With First-Generation Direct-Acting AgentsChristopher Woodrell, Jeffrey Weiss, Andrea Branch, et al.
Pageof 3